East Greenbush, NY, United States of America

John Chen

This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Chen. Retrieved from https://idiyas.com/inventor/john-chen-ne0egpib

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of John Chen

Introduction

John Chen is an accomplished inventor based in East Greenbush, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of cell culture media. With a total of 5 patents to his name, Chen's work has had a notable impact on protein production and cell culture methodologies.

Latest Patents

Among his latest patents, Chen has developed innovative cell culture media specifically designed for eukaryotic cells. These media are essential for various applications, including cell culture and protein production from cells. His contributions in this area are paving the way for advancements in biopharmaceuticals and research.

Career Highlights

John Chen is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its focus on developing medicines for serious diseases. His role at Regeneron allows him to apply his expertise in cell culture and contribute to groundbreaking research and development efforts.

Collaborations

Throughout his career, Chen has collaborated with talented individuals such as Wei Xue and Carolyn Scott. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their respective fields.

Conclusion

John Chen's work exemplifies the spirit of innovation in biotechnology. His patents and contributions to cell culture media are vital for advancing research and therapeutic applications. His ongoing efforts at Regeneron Pharmaceuticals, Inc. continue to shape the future of biopharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…